Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP881038.RAkQMBNtz8Y7DLCDuxMSzmgvef4A-Wr8S-kOJP1g7q2oE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP881038.RAkQMBNtz8Y7DLCDuxMSzmgvef4A-Wr8S-kOJP1g7q2oE130_assertion type Assertion NP881038.RAkQMBNtz8Y7DLCDuxMSzmgvef4A-Wr8S-kOJP1g7q2oE130_head.
- NP881038.RAkQMBNtz8Y7DLCDuxMSzmgvef4A-Wr8S-kOJP1g7q2oE130_assertion description "[In addition, PCI-32765 inhibits activation-induced proliferation of CLL cells in vitro, and effectively blocks survival signals provided externally to CLL cells from the microenvironment including soluble factors (CD40L, BAFF, IL-6, IL-4, and TNF-?), fibronectin engagement, and stromal cell contact.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP881038.RAkQMBNtz8Y7DLCDuxMSzmgvef4A-Wr8S-kOJP1g7q2oE130_provenance.
- NP881038.RAkQMBNtz8Y7DLCDuxMSzmgvef4A-Wr8S-kOJP1g7q2oE130_assertion evidence source_evidence_literature NP881038.RAkQMBNtz8Y7DLCDuxMSzmgvef4A-Wr8S-kOJP1g7q2oE130_provenance.
- NP881038.RAkQMBNtz8Y7DLCDuxMSzmgvef4A-Wr8S-kOJP1g7q2oE130_assertion SIO_000772 21422473 NP881038.RAkQMBNtz8Y7DLCDuxMSzmgvef4A-Wr8S-kOJP1g7q2oE130_provenance.
- NP881038.RAkQMBNtz8Y7DLCDuxMSzmgvef4A-Wr8S-kOJP1g7q2oE130_assertion wasDerivedFrom befree-2016 NP881038.RAkQMBNtz8Y7DLCDuxMSzmgvef4A-Wr8S-kOJP1g7q2oE130_provenance.
- NP881038.RAkQMBNtz8Y7DLCDuxMSzmgvef4A-Wr8S-kOJP1g7q2oE130_assertion wasGeneratedBy ECO_0000203 NP881038.RAkQMBNtz8Y7DLCDuxMSzmgvef4A-Wr8S-kOJP1g7q2oE130_provenance.